Liver X receptor biology and pharmacology: New pathways, challenges and opportunities

Trends in Pharmacological Sciences

Volumn 33, Issue 7, 2012, Pages 394-404

  Jakobsson, Tomas ^a   Treuter, Eckardt ^a   Gustafsson, Jan Åke ^a,b   Steffensen, Knut R ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b University of Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; LXR 623; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

CANCER CELL; CANCER PREVENTION; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CHRONIC INFLAMMATION; CONFORMATIONAL TRANSITION; DEGENERATIVE DISEASE; DENDRITIC CELL; DRUG TARGETING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; LIGAND BINDING; LIPID METABOLISM; METABOLIC DISORDER; METABOLIC REGULATION; NEUROLOGIC DISEASE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SKIN DISEASE;

AMINO ACID SEQUENCE; ANIMALS; CHOLESTEROL; DRUG DESIGN; HOMEOSTASIS; HUMANS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR TARGETED THERAPY; ORPHAN NUCLEAR RECEPTORS; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 84862687669     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2012.03.013     Document Type: Review

References (130)

1. McKenna, N.J. et al. (2009) Evolution of NURSA, the nuclear receptor signaling atlas. Mol. Endocrinol. 23, 740-746
2. Gronemeyer, H. et al. (2004) Principles for modulation of the nuclear receptor superfamily. Nat. Rev. Drug Discov. 3, 950-964
3. Thomas, C. and Gustafsson, J.A. (2011) The different roles of ER subtypes in cancer biology and therapy. Nat. Rev. Cancer 11, 597-608
4. Knudsen, K.E. and Penning, T.M. (2010) Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer. Trends Endocrinol. Metab. 21, 315-324
5. Moore, J.T. et al. (2006) The nuclear receptor superfamily and drug discovery. ChemMedChem 1, 504-523
6. Zelcer, N. and Tontonoz, P. (2006) Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest. 116, 607-614
7. Bourguet, W. et al. (2000) Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol. Cell 5, 289-298
8. Farnegardh, M. et al. (2003) The three-dimensional structure of the liver X receptor beta reveals a flexible ligand-binding pocket that can accommodate fundamentally different ligands. J. Biol. Chem. 278, 38821-38828
9. Apfel, R. et al. (1994) A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol. Cell. Biol. 14, 7025-7035
10. Teboul, M. et al. (1995) OR-1, a member of the nuclear receptor superfamily that interacts with the 9-cis-retinoic acid receptor. Proc. Natl. Acad. Sci. U.S.A. 92, 2096-2100
11. Viennois, E. et al. (2012) Selective liver X receptor modulators (SLiMs): what use in human health? Mol. Cell. Endocrinol. 351, 129-141
12. Svensson, S. et al. (2003) Crystal structure of the heterodimeric complex of LXRα and RXRβ ligand-binding domains in a fully agonistic conformation. EMBO J. 22, 4625-4633
13. Williams, S. et al. (2003) X-Ray crystal structure of the liver X receptor b ligand binding domain: regulation by a histidine-tryptophan switch. J Biol Chem 278, 27138-27143
14. Peet, D.J. et al. (1998) Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRα. Cell 93, 693-704
15. Repa, J.J. et al. (2000) Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes Dev. 14, 2819-2830
16. Alberti, S. et al. (2001) Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice. J. Clin. Invest. 107, 565-573
17. Yvan-Charvet, L. et al. (2007) Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J. Clin. Invest. 117, 3900-3908
18. Wang, X. et al. (2007) Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J. Clin. Invest. 117, 2216-2224
19. Naik, S.U. et al. (2006) Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation 113, 90-97
20. Brunham, L.R. et al. (2006) Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels. Circ. Res. 99, 672-674
21. Feig, J.E. et al. (2010) LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. J. Clin. Invest. 120, 4415-4424
22. Zelcer, N. et al. (2009) LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 325, 100-104
23. Gerin, I. et al. (2005) LXRβ is required for adipocyte growth, glucose homeostasis, and b cell function. J. Biol. Chem. 280, 23024-23031
24. Kalaany, N.Y. et al. (2005) LXRs regulate the balance between fat storage and oxidation. Cell Metab. 1, 231-244
25. Korach-Andre, M. et al. (2010) Separate and overlapping metabolic functions of LXRα and LXRβ in C57Bl/6 female mice. Am. J. Physiol. Endocrinol. Metab. 298, E167-E178
26. Korach-Andre, M. et al. (2011) Both liver-X receptor (LXR) isoforms control energy expenditure by regulating brown adipose tissue activity. Proc. Natl. Acad. Sci. U.S.A. 108, 403-408
27. Steffensen, K.R. et al. (2004) Genome-wide expression profiling; a panel of mouse tissues discloses novel biological functions of liver X receptors in adrenals. J. Mol. Endocrinol. 33, 609-622
28. Joseph, S.B. et al. (2004) LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119, 299-309
29. Valledor, A.F. et al. (2004) Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis. Proc. Natl. Acad. Sci. U.S.A. 101, 17813-17818
30. Gonzalez, N.A. et al. (2009) Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31, 245-258
31. Hong, C. et al. (2012) Coordinate regulation of neutrophil homeostasis by liver X receptors in mice. J. Clin. Invest. 122, 337-347
32. Schmuth, M. et al. (2008) Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology. J. Lipid Res. 49, 499-509
33. Cheng, O. et al. (2010) Activation of liver X receptor reduces global ischemic brain injury by reduction of nuclear factor-κB. Neuroscience 166, 1101-1109
34. Paterniti, I. et al. (2010) Liver X receptor agonist treatment regulates inflammatory response after spinal cord trauma. J. Neurochem. 112, 611-624
35. Lee, J.H. et al. (2009) Differential SUMOylation of LXRα and LXRβ mediates transrepression of STAT1 inflammatory signaling in IFN-γ-stimulated brain astrocytes. Mol. Cell 35, 806-817
36. Morales, J.R. et al. (2008) Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke. Circulation 118, 1450-1459
37. Repa, J.J. et al. (2007) Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse. J. Neurosci. 27, 14470-14480
38. -/- mice, a model of adult neuron disease. J. Neuropathol. Exp. Neurol. 69, 593-605
39. Lefterov, I. et al. (2007) Expression profiling in APP23 mouse brain: inhibition of Aβ amyloidosis and inflammation in response to LXR agonist treatment. Mol. Neurodegen. 2, 20
40. Lee, C.S. et al. (2006) Oxysterols suppress inducible nitric oxide synthase expression in lipopolysaccharide-stimulated astrocytes through liver X receptor. Neuroreport 17, 183-187
41. Zhang-Gandhi, C.X. and Drew, P.D. (2007) Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes. J. Neuroimmunol. 183, 50-59
42. Zelcer, N. et al. (2007) Attenuation of neuroinflammation and Alzheimer's disease pathology by liver X receptors. Proc. Natl. Acad. Sci. U.S.A. 104, 10601-10606
43. Walcher, D. et al. (2010) LXR activation inhibits chemokine-induced CD4-positive lymphocyte migration. Basic Res. Cardiol. 105, 487-494
44. Walcher, D. et al. (2006) LXR activation reduces proinflammatory cytokine expression in human CD4-positive lymphocytes. Arterioscler. Thromb. Vasc. Biol. 26, 1022-1028
45. Heine, G. et al. (2009) Liver X receptors control IgE expression in B cells. J. Immunol. 182, 5276-5282
46. Chang, L. et al. (2007) Liver-X-receptor activator prevents homocysteine-induced production of IgG antibodies from murine B lymphocytes via the ROS-NF-kB pathway. Biochem. Biophys. Res. Commun. 357, 772-778
47. Myhre, A.E. et al. (2008) Liver X receptor is a key regulator of cytokine release in human monocytes. Shock 29, 468-474
48. Mallat, A. and Lotersztajn, S. (2011) The liver X receptor in hepatic stellate cells: a novel antifibrogenic target? J. Hepatol. 55, 1452-1454
49. Beaven, S.W. et al. (2011) Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease. Gastroenterology 140, 1052-1062
50. Wang, Y.Y. et al. (2006) Activation of the liver X receptor protects against hepatic injury in endotoxemia by suppressing Kupffer cell activation. Shock 25, 141-146
51. Scholz, H. et al. (2009) The synthetic liver X receptor agonist GW3965 reduces tissue factor production and inflammatory responses in human islets in vitro. Diabetologia 52, 1352-1362
52. Delvecchio, C.J. et al. (2007) Liver X receptor stimulates cholesterol efflux and inhibits expression of proinflammatory mediators in human airway smooth muscle cells. Mol. Endocrinol. 21, 1324-1334
53. Remen, K.M. et al. (2011) Activation of liver X receptor (LXR) inhibits receptor activator of nuclear factor κB ligand (RANKL)-induced osteoclast differentiation in an LXRβ-dependent mechanism. J. Biol. Chem. 286, 33084-33094
54. Geyeregger, R. et al. (2007) Liver X receptors regulate dendritic cell phenotype and function through blocked induction of the actin-bundling protein fascin. Blood 109, 4288-4295
55. Villablanca, E.J. et al. (2010) Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. Nat. Med. 16, 98-105
56. Torocsik, D. et al. (2010) Activation of liver X receptor sensitizes human dendritic cells to inflammatory stimuli. J. Immunol. 184, 5456-5465
57. Venteclef, N. et al. (2010) GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRβ in the hepatic acute phase response. Genes Dev. 24, 381-395
58. -/- mice fed a high-fat/high-cholesterol diet. Inflammation 30, 105-117
59. Blaschke, F. et al. (2006) A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor. Circ. Res. 99, e88-e99
60. Wang, Y.Y. et al. (2009) Liver X receptor agonist GW3965 dose-dependently regulates LPS-mediated liver injury and modulates post-transcriptional TNFα production and p38 MAPK activation in liver macrophages. Shock 32, 548-553
61. Wang, Y.Y. et al. (2011) Liver X receptor protects against liver injury in sepsis caused by rodent cecal ligation and puncture. Surg. Infect. 12, 283-289
62. Kiss, E. et al. (2011) Suppression of chronic damage in renal allografts by liver X receptor (LXR) activation relevant contribution of macrophage LXRα. Am. J. Pathol. 179, 92-103
63. Birrell, M.A. et al. (2007) Novel role for the liver X nuclear receptor in the suppression of lung inflammatory responses. J. Biol. Chem. 282, 31882-31890
64. Smoak, K. et al. (2008) Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense. J. Immunol. 180, 3305-3312
65. Korf, H. et al. (2009) Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice. J. Clin. Invest. 119, 1626-1637
66. Bruhn, K.W. et al. (2010) LXR deficiency confers increased protection against visceral Leishmania infection in mice. PLoS Negl. Trop. Dis. 4, e886
67. Gong, H. et al. (2009) Activation of the liver X receptor prevents lipopolysaccharide-induced lung injury. J. Biol. Chem. 284, 30113-30121
68. Steinman, R.M. et al. (2003) The interaction of immuno-deficiency viruses with dendritic cells. Curr. Top. Microbiol. Immunol. 276, 1-30
69. Hanley, T.M. et al. (2010) PPARγ and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infection. PLoS Pathog. 6, e1000981
70. Morrow, M.P. et al. (2010) Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP-binding cassette transporter A1. Mol. Pharmacol. 78, 215-225
71. Hanley, T.M. and Viglianti, G.A. (2011) Nuclear receptor signaling inhibits HIV-1 replication in macrophages through multiple transrepression mechanisms. J. Virol. 85, 10834-10850
72. Asquith, D.L. et al. (2009) Liver X receptor agonism promotes articular inflammation in murine collagen-induced arthritis. Arthritis Rheum. 60, 2655-2665
73. Asquith, D.L. et al. (2011) Simultaneous activation of the liver X receptors (LXRα and LXRβ) drives murine collagen-induced arthritis disease pathology. Ann. Rheum. Dis. 70, 2225-2228
74. Collins-Racie, L.A. et al. (2009) Global analysis of nuclear receptor expression and dysregulation in human osteoarthritic articular cartilage: reduced LXR signaling contributes to catabolic metabolism typical of osteoarthritis. Osteoarthr. Cartil. 17, 832-842
75. Park, M.C. et al. (2010) Liver X receptor agonist prevents the evolution of collagen-induced arthritis in mice. Rheumatology (Oxford) 49, 882-890
76. Li, N. et al. (2010) LXR modulation blocks prostaglandin E2 production and matrix degradation in cartilage and alleviates pain in a rat osteoarthritis model. Proc. Natl. Acad. Sci. U.S.A. 107, 3734-3739
77. Koldamova, R. et al. (2010) The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration. Biochim. Biophys. Acta 1801, 824-830
78. Saijo, K. et al. (2010) Nuclear receptors, inflammation, and neurodegenerative diseases. Adv. Immunol. 106, 21-59
79. Terwel, D. et al. (2011) Critical role of astroglial apolipoprotein E and liver X receptor-α expression for microglial Aβ phagocytosis. J. Neurosci. 31, 7049-7059
80. Hindinger, C. et al. (2006) Liver X receptor activation decreases the severity of experimental autoimmune encephalomyelitis. J. Neurosci. Res. 84, 1225-1234
81. Xu, J. et al. (2009) Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity. J. Leukoc. Biol. 86, 401-409
82. Cui, G. et al. (2011) Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. J. Clin. Invest. 121, 658-670
83. Fan, X. et al. (2008) Expression of liver X receptor β is essential for formation of superficial cortical layers and migration of later-born neurons. Proc. Natl. Acad. Sci. U.S.A. 105, 13445-13450
84. Kim, H.J. et al. (2008) Liver X receptor beta (LXRβ): a link between β-sitosterol and amyotrophic lateral sclerosis-Parkinson's dementia. Proc. Natl. Acad. Sci. U.S.A. 105, 2094-2099
85. Sacchetti, P. et al. (2009) Liver X receptors and oxysterols promote ventral midbrain neurogenesis in vivo and in human embryonic stem cells. Cell Stem Cell 5, 409-419
86. Chuu, C.P. (2011) Modulation of liver X receptor signaling as a prevention and therapy for colon cancer. Med. Hypothese 76, 697-699
87. Fukuchi, J. et al. (2004) Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Cancer Res. 64, 7686-7689
88. Chuu, C.P. et al. (2006) Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist. Cancer Res. 66, 6482-6486
89. Bensinger, S.J. et al. (2008) LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 134, 97-111
90. Lo Sasso, G. et al. (2010) Down-regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes. Hepatology 51, 1334-1344
91. Guo, D. et al. (2011) An LXR agonist promotes GBM cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. Cancer Discov. 1, 442-456
92. Wagner, B.L. et al. (2003) Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression. Mol. Cell. Biol. 23, 5780-5789
93. Boergesen, M. et al. (2012) Genome-wide profiling of liver X receptor, retinoid X receptor and peroxisome proliferator activated receptor a in mouse liver reveals extensive sharing of binding sites. Mol. Cell. Biol. 32, 852-867
94. Pehkonen, P. et al. (2012) Genome-wide landscape of liver X receptor chromatin binding and gene regulation in human macrophages. BMC Genomics 13, 50
95. Heinz, S. et al. (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576-589
96. Jakobsson, T. et al. (2009) GPS2 is required for cholesterol efflux by triggering histone demethylation, LXR recruitment, and coregulator assembly at the ABCG1 locus. Mol. Cell 34, 510-518
97. Li, X. et al. (2007) SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol. Cell 28, 91-106
98. Kim, K.H. et al. (2009) Liver X receptor ligands suppress ubiquitination and degradation of LXRa by displacing BARD1/BRCA1. Mol. Endocrinol. 23, 466-474
99. Chen, M. et al. (2006) Phosphorylation of the liver X receptors. FEBS Lett. 580, 4835-4841
100. Torra, I.P. et al. (2008) Phosphorylation of liver X receptor α selectively regulates target gene expression in macrophages. Mol. Cell. Biol. 28, 2626-2636
101. Yamamoto, T. et al. (2007) Protein kinase A suppresses sterol regulatory element-binding protein-1C expression via phosphorylation of liver X receptor in the liver. J. Biol. Chem. 282, 11687-11695
102. Anthonisen, E.H. et al. (2010) Nuclear receptor liver X receptor is O-GlcNAc-modified in response to glucose. J. Biol. Chem. 285, 1607-1615
103. Ghisletti, S. et al. (2007) Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARg. Mol. Cell 25, 57-70
104. Venteclef, N. et al. (2011) Metabolic nuclear receptor signaling and the inflammatory acute phase response. Trends Endocrinol. Metab. 22, 333-343
105. Bensinger, S.J. and Tontonoz, P. (2008) Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 454, 470-477
106. Katz, A. et al. (2009) Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants. J. Clin. Pharmacol. 49, 643-649
107. Bradley, M.N. et al. (2007) Ligand activation of LXR β reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR α and apoE. J. Clin. Invest. 117, 2337-2346
108. Yasuda, T. et al. (2010) Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo. Arterioscler. Thromb. Vasc. Biol. 30, 781-786
109. Lo Sasso, G. et al. (2010) Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis. Cell Metab. 12, 187-193
110. Hu, X. et al. (2012) LXRβ activation increases intestinal cholesterol absorption leading to an atherogenic lipoprotein profile. J. Intern. Med. (http://dx.doi.org/10.1111/j.1365-2796.2012.02529.x)
111. Fontaine, C. et al. (2007) Liver X receptor activation potentiates the lipopolysaccharide response in human macrophages. Circ. Res. 101, 40-49
112. Hall, J.M. and McDonnell, D.P. (2007) The molecular mechanisms underlying the proinflammatory actions of thiazolidinediones in human macrophages. Mol. Endocrinol. 21, 1756-1768
113. Chao, E.Y. et al. (2008) Structure-guided design of N-phenyl tertiary amines as transrepression-selective liver X receptor modulators with anti-inflammatory activity. J. Med. Chem. 51, 5758-5765
114. Wirfalt, E. et al. (2009) Associations between food patterns defined by cluster analysis and colorectal cancer incidence in the NIH-AARP diet and health study. Eur. J. Clin. Nutr. 63, 707-717
115. Plat, J. et al. (2005) Plant sterols and stanols: effects on mixed micellar composition and LXR (target gene) activation. J. Lipid Res. 46, 2468-2476
116. Ronco, A. et al. (1999) Vegetables, fruits, and related nutrients and risk of breast cancer: a case-control study in Uruguay. Nutr. Cancer 35, 111-119
117. McCann, S.E. et al. (2005) Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr. Cancer 53, 33-41
118. De Stefani, E. et al. (2000) Plant sterols and risk of stomach cancer: a case-control study in Uruguay. Nutr. Cancer 37, 140-144
119. Mendilaharsu, M. et al. (1998) Phytosterols and risk of lung cancer: a case-control study in Uruguay. Lung Cancer 21, 37-45
120. Patel, R. et al. (2011) LXRβ is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice. J. Clin. Invest. 121, 431-441
121. Kotokorpi, P. et al. (2007) Physiological differences between human and rat primary hepatocytes in response to liver X receptor activation by 3-[3-[N-(2-chloro-3-trifluoromethylbenzyl)-(2,2-diphenylethyl)amino]propyl oxy]phenylacetic acid hydrochloride (GW3965). Mol. Pharmacol. 72, 947-955
122. Repa, J.J. et al. (2000) Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289, 1524-1529
123. Collins, J.L. et al. (2002) Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines. J. Med. Chem. 45, 1963-1966
124. Hu, B. et al. (2007) Further modification on phenyl acetic acid based quinolines as liver X receptor modulators. Bioorg. Med. Chem. 15, 3321-3333
125. Zuercher, W.J. et al. (2010) Discovery of tertiary sulfonamides as potent liver X receptor antagonists. J. Med. Chem. 53, 3412-3416
126. Hu, B. et al. (2010) Identification of phenylsulfone-substituted quinoxaline (WYE-672) as a tissue selective liver X-receptor (LXR) agonist. J. Med. Chem. 53, 3296-3304
127. Huang, W.C. et al. (2004) Crystal structures of the human SUMO-2 protein at 1.6 Å and 1.2 Å resolution: implication on the functional differences of SUMO proteins. Eur. J. Biochem. 271, 4114-4122
128. Stenson, B.M. et al. (2011) Liver X receptor (LXR) regulates human adipocyte lipolysis. J. Biol. Chem. 286, 370-379
129. Perissi, V. et al. (2004) A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116, 511-526
130. Huang, W. et al. (2011) Coronin 2A mediates actin-dependent derepression of inflammatory response genes. Nature 470, 414-418